Current and Next Steps Toward Prediction of Human Dose for Gene Therapy Using Translational Dose-Response Studies
Clin Pharmacol Ther
.
2021 Nov;110(5):1176-1179.
doi: 10.1002/cpt.2374.
Epub 2021 Aug 8.
Authors
Sergey Aksenov
1
,
John C Roberts
2
,
Ganesh Mugundu
3
,
Karen Thudium Mueller
4
,
Indranil Bhattacharya
5
,
Michael A Tortorici
2
Affiliations
1
Early Development Analytics, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
2
Clinical Pharmacology and Pharmacometrics, CSL Behring, King of Prussia, Pennsylvania, USA.
3
Cell Therapy Pharmacology and Modeling, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, USA.
4
Translational Sciences, GentiBio, Cambridge, Massachusetts, USA.
5
Quantitative Clinical Pharmacology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, USA.
PMID:
34365642
DOI:
10.1002/cpt.2374
No abstract available
Publication types
Comment
MeSH terms
Genetic Therapy*
Humans
Translational Research, Biomedical*